BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu SY, Wu QY, Zhang CX, Wang Q, Ling J, Huang XT, Sun X, Yuan M, Wu D, Yin HF. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1. Biochem Biophys Res Commun 2018;505:309-16. [PMID: 30249397 DOI: 10.1016/j.bbrc.2018.09.102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xing Y, Ruan G, Ni H, Qin H, Chen S, Gu X, Shang J, Zhou Y, Tao X, Zheng L. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. Front Immunol 2021;12:624725. [PMID: 34084160 DOI: 10.3389/fimmu.2021.624725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. Int Rev Immunol 2021;40:197-216. [PMID: 33258393 DOI: 10.1080/08830185.2020.1845670] [Reference Citation Analysis]
3 Arora L, Pal D. Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression. Front Oncol 2021;11:596798. [PMID: 33763348 DOI: 10.3389/fonc.2021.596798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tuo Z, Zhang Y, Wang X, Dai S, Liu K, Xia D, Wang J, Bi L. RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers. BMC Cancer 2022;22:523. [PMID: 35534796 DOI: 10.1186/s12885-022-09632-y] [Reference Citation Analysis]
5 Guo L, Hua K. Cervical Cancer: Emerging Immune Landscape and Treatment. Onco Targets Ther 2020;13:8037-47. [PMID: 32884290 DOI: 10.2147/OTT.S264312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen K, Pan G. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients. Pathol Res Pract 2019;215:152686. [PMID: 31711673 DOI: 10.1016/j.prp.2019.152686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Xiao Z, Chen S, Feng S, Li Y, Zou J, Ling H, Zeng Y, Zeng X. Function and mechanisms of microRNA-20a in colorectal cancer. Exp Ther Med 2020;19:1605-16. [PMID: 32104211 DOI: 10.3892/etm.2020.8432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Arora S, Khan S, Zaki A, Tabassum G, Mohsin M, Bhutto HN, Ahmad T, Fatma T, Syed MA. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.002] [Reference Citation Analysis]
9 Wang SZ, Zhang YL, Shi HB. Potential Repressive Impact of microRNA-20a on Renal Tubular Damage in Diabetic Kidney Disease by Targeting C-X-C Motif Chemokine Ligand 6. Arch Med Res 2021;52:58-68. [PMID: 32868134 DOI: 10.1016/j.arcmed.2020.08.005] [Reference Citation Analysis]
10 Shekari N, Javadian M, Ghaffari S, Baradaran B, Darabi M, Kazemi T. DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer. J Gastrointest Cancer 2020;51:545-51. [PMID: 31368060 DOI: 10.1007/s12029-019-00280-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]